Critical Care

official impact factor 4.60

Open Access Highly Access

Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

Bernd Muellejans*, Thomas Matthey, Joachim Scholpp and Markus Schill

Critical Care 2006, 10:R91 doi:10.1186/cc4939

Accesses  

  • Last 30 days: 136 accesses
  • Last 365 days: 1634 accesses
  • All time: 17181 accesses